News & Trends - Pharmaceuticals
Government’s bold medicines policy falls short of delivering promised savings
A health reform designed to cut costs for patients, free up clinician time, and deliver savings to the federal budget […]
MoreNews & Trends - Pharmaceuticals
New collective demands end to decades of neglect in gynaecological cancer
For nearly two decades, gynaecological cancers have remained in the shadows – overlooked, underfunded, and devastatingly fatal for thousands of […]
MoreNews & Trends - Pharmaceuticals
The challenge of pricing combination therapies: Why payer involvement is no longer optional
The rise of combination and sequencing therapies involving multiple medicines continues to expose a significant challenge in health technology assessment […]
MoreNews & Trends - Pharmaceuticals
NSW Health Minister accused of ‘weaponising cancer patients’
The NSW Health Minister, Ryan Park, has been accused of exploiting cancer patients to wage a political attack against public […]
MoreNews & Trends - Pharmaceuticals
Oncologists pioneer liquid biopsy-guided treatment in lung cancer
Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]
MoreNews & Trends - Pharmaceuticals
UCB secures dermatology indication with first dual IL-17A/F inhibitor
UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]
MoreNews & Trends - Pharmaceuticals
PBAC issues criticism of pharma industry’s reimbursement submissions
The Pharmaceutical Benefits Advisory Committee (PBAC) Chair, Professor Robyn Ward, and Deputy Chair, Jo Watson, have issued a rebuke to […]
MoreNews & Trends - Pharmaceuticals
Australian clinicians uncover new toxicity linked to Roche’s lymphoma therapy
A team of Australian haematologists has uncovered a previously unreported immune-related toxicity associated with Roche Product’s dual-targeting CD3-CD20 bispecific antibody, […]
MoreNews & Trends - Pharmaceuticals
Long-term efficacy of Eli Lilly’s obesity drug in the spotlight
New analyses from the SURMOUNT-1 trials shed light on the long-term efficacy of Eli Lilly’s dual GIP and GLP-1 receptor […]
MoreNews & Trends - Pharmaceuticals
Patient advocacy groups demand end to HTA reform delays as election nears
The Health Technology Assessment (HTA) Review Implementation Advisory Group (IAG), led by Professor Andrew Wilson, convenes today (10 April) for […]
MoreRecent Posts in Pharma, MedTech & Biotech
Reimagining remote care with Australia’s first virtual hospital
April 24, 2025
in Digital & Innovation
Health Minister and Opposition face off at the National Press Club
April 24, 2025
in News & Trends - MedTech & Diagnostics
GSK nabs label expansion for RSV vaccine
April 24, 2025
in News & Trends - Pharmaceuticals
Low-value imaging linked to high human cost
April 23, 2025
in News & Trends - MedTech & Diagnostics
Government’s bold medicines policy falls short of delivering promised savings
April 23, 2025
in News & Trends - Pharmaceuticals
New collective demands end to decades of neglect in gynaecological cancer
April 23, 2025
in News & Trends - Pharmaceuticals
Audit finds public-private hospital failing patients while Healthscope seeks escape
April 22, 2025
in News & Trends - MedTech & Diagnostics
The challenge of pricing combination therapies: Why payer involvement is no longer optional
April 22, 2025
in News & Trends - Pharmaceuticals
Follow Us
Partner with us
Digital & Innovation
Reimagining remote care with Australia’s first virtual hospital
Australia’s first virtual hospital is taking on a new role as a national testbed for advancing the future of patient-facing […]
MoreNews & Trends - MedTech & Diagnostics
Health Minister and Opposition face off at the National Press Club
In a blistering showdown at the National Press Club, Federal Health Minister, Mark Butler, and his Opposition counterpart Senator Anne […]
MoreNews & Trends - Pharmaceuticals
GSK nabs label expansion for RSV vaccine
Coinciding with World Immunisation Week (24-30 April), GSK has secured TGA approval for its respiratory syncytial virus (RSV) vaccine, marking […]
MoreNews & Trends - MedTech & Diagnostics
Low-value imaging linked to high human cost
Imagining has become a cornerstone of modern medicine, for their ability to detect cancers, guide surgeries, and uncover internal injuries […]
More